Pink1 Deficient Dopaminergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PINK1 (PTEN-induced kinase 1) deficiency leads to familial Parkinson's disease through impaired mitophagy. PINK1 mutations cause early-onset autosomal recessive Parkinson's disease, and PINK1-deficient neurons serve as a critical model for understanding mitochondrial quality control in dopaminergic neurons.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
- Serine/threonine-protein kinase localized to mitochondria
- Normally degraded in healthy mitochondria
- Accumulates on outer mitochondrial membrane when mitochondria are damaged
- Recruits and activates Parkin for mitophagy
- Failure to identify damaged mitochondria
- Accumulation of dysfunctional mitochondria
- Reduced ATP production
- Increased reactive oxygen species (ROS)
- Impaired calcium handling
- Decreased complex I activity
- Reduced mitochondrial membrane potential
- Increased mitochondrial DNA mutations
- Swollen and fragmented mitochondria
- Reduced neurite length and branching
- Increased apoptosis susceptibility
- Lewy body-like inclusions
- Progressive neuronal death
- Patient-derived iPSC dopaminergic neurons with PINK1 mutations
- CRISPR/Cas9 PINK1 knockout in dopaminergic cell lines
- PINK1 siRNA knockdown in primary neuronal cultures
- PINK1 knockout mice
- PINK1 knockdown in rat substantia nigra
- Drosophila melanogaster PINK1 models
- AAV-PINK1 delivery to substantia nigra
- CRISPR-based PINK1 correction
- PINK1 analog small molecules
- Mitochondrial antioxidants (MitoQ, CoQ10)
- Mitophagy enhancers
- ATP restoration compounds
The study of Pink1 Deficient Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Valente et al., PINK1 mutations cause familial Parkinson's disease (2004)
- Pickrell & Youle, The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease (2015)
- Schapira et al., Mitochondrial complex I deficiency in Parkinson's disease (1989)
- Matsuda et al., PINK1 stabilized by mitochondrial depolarization recruits Parkin (2008)